ALISON TAGLIAFERRO: Open Payments
NPI 1831942440 · ENGLEWOOD CLIFFS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,517 in 88 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,226 · 2025 $1,517
Food & beverage: $1,466Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $339 |
| Janssen Biotech, Inc. | 19 | $338 |
| Phathom Pharmaceuticals, Inc. | 9 | $141 |
| Aimmune Therapeutics, Inc. | 7 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $56 |
| Ipsen Biopharmaceuticals, Inc | 3 | $55 |
| Ardelyx, Inc. | 3 | $53 |
| Ferring Pharmaceuticals Inc. | 2 | $51 |
| Braintree Laboratories, Inc. | 2 | $43 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, ZENPEP, SKYRIZI, OMVOH, IQIRVO, LINZESS.
Industry payments across NJ — which companies pay providers there.
